| Primary |
| Product Used For Unknown Indication |
46.2% |
| Appendicectomy |
7.7% |
| Pain |
7.7% |
| Analgesic Therapy |
6.2% |
| Glaucoma |
6.2% |
| Anaesthesia Reversal |
3.1% |
| Procedural Pain |
3.1% |
| Analgesia |
1.5% |
| Arthralgia |
1.5% |
| Chest Pain |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Gouty Arthritis |
1.5% |
| Headache |
1.5% |
| Induction Of Anaesthesia |
1.5% |
| Infection Prophylaxis |
1.5% |
| Myalgia |
1.5% |
| Nerve Compression |
1.5% |
| Osteoarthritis |
1.5% |
| Pain Relief |
1.5% |
| Pancreatitis |
1.5% |
|
| Pulmonary Alveolar Haemorrhage |
12.5% |
| Renal Failure Acute |
12.5% |
| Drug Administration Error |
4.2% |
| Duodenal Ulcer |
4.2% |
| Embolia Cutis Medicamentosa |
4.2% |
| Gastrointestinal Haemorrhage |
4.2% |
| Haemorrhage Intracranial |
4.2% |
| Hallucination |
4.2% |
| Hepatitis Cholestatic |
4.2% |
| Injection Site Infection |
4.2% |
| Injection Site Pain |
4.2% |
| Multi-organ Disorder |
4.2% |
| Neck Pain |
4.2% |
| Nephrolithiasis |
4.2% |
| Ocular Hyperaemia |
4.2% |
| Oxygen Saturation Decreased |
4.2% |
| Pericarditis |
4.2% |
| Pneumonia |
4.2% |
| Polyneuropathy |
4.2% |
| Product Quality Issue |
4.2% |
|
| Secondary |
| Headache |
31.9% |
| Bone Disorder |
13.3% |
| Respiratory Disorder |
13.3% |
| Product Used For Unknown Indication |
11.3% |
| Pain |
8.6% |
| Anaesthesia |
3.0% |
| Hepatic Mass |
3.0% |
| Local Anaesthesia |
2.6% |
| Premedication |
1.7% |
| Asthma |
1.6% |
| General Anaesthesia |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.4% |
| Postoperative Analgesia |
1.2% |
| Procedural Pain |
1.2% |
| Eye Infection Toxoplasmal |
1.0% |
| Analgesic Therapy |
0.9% |
| Drug Use For Unknown Indication |
0.7% |
| Nausea |
0.7% |
| Back Pain |
0.5% |
| Hypertension |
0.5% |
|
| Inflammation |
22.2% |
| Atrial Fibrillation |
8.9% |
| Oedema |
6.7% |
| Postoperative Ileus |
6.7% |
| Weight Increased |
6.7% |
| Haemorrhage |
4.4% |
| Hyponatraemia |
4.4% |
| Rash |
4.4% |
| Renal Failure Acute |
4.4% |
| Renal Tubular Necrosis |
4.4% |
| Urticaria |
4.4% |
| Ventricular Fibrillation |
4.4% |
| Acute Myocardial Infarction |
2.2% |
| Anaphylactic Shock |
2.2% |
| Blood Pressure Decreased |
2.2% |
| Blood Pressure Inadequately Controlled |
2.2% |
| Drug Administration Error |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Drug Ineffective |
2.2% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.4% |
| Pain |
13.8% |
| Prophylaxis |
9.3% |
| Drug Use For Unknown Indication |
4.3% |
| Hypertension |
3.1% |
| Abdominal Pain |
3.1% |
| Migraine |
2.9% |
| Contraception |
2.7% |
| Depression |
2.6% |
| Nausea |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Anxiety |
2.3% |
| Crohn's Disease |
2.3% |
| Pancreatic Pseudocyst |
2.3% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Procedural Pain |
1.9% |
| Diabetes Mellitus |
1.8% |
| Headache |
1.8% |
| Pain In Extremity |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
|
| Pulmonary Embolism |
21.7% |
| Pain |
10.5% |
| Vomiting |
10.5% |
| Deep Vein Thrombosis |
7.2% |
| Nausea |
4.6% |
| Weight Decreased |
4.6% |
| Eye Laser Surgery |
3.9% |
| Female Genital Tract Fistula |
3.9% |
| Renal Failure Acute |
3.9% |
| Vision Blurred |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Mucosal Inflammation |
2.6% |
| Renal Tubular Necrosis |
2.6% |
| Serotonin Syndrome |
2.6% |
| Suicide Attempt |
2.6% |
| Tremor |
2.6% |
| Vaginal Haemorrhage |
2.6% |
| Weight Increased |
2.6% |
| Anaemia |
2.0% |
| Anxiety |
2.0% |
|
